ScholarIQanswers from OpenAlex

Reamputation after Minor Foot Amputation in Diabetic Patients: Risk Factors Leading to Limb Loss

PaperCitations, authors & open-access status

Reamputation after Minor Foot Amputation in Diabetic Patients: Risk Factors Leading to Limb Loss is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Reamputation after Minor Foot Amputation in Diabetic Patients: Risk Factors Leading to Limb Loss have?

ScholarIQcitation count

Reamputation after Minor Foot Amputation in Diabetic Patients: Risk Factors Leading to Limb Loss has 46 citations in the OpenAlex counts ScholarIQ stores.

When was Reamputation after Minor Foot Amputation in Diabetic Patients: Risk Factors Leading to Limb Loss published?

ScholarIQyear

Reamputation after Minor Foot Amputation in Diabetic Patients: Risk Factors Leading to Limb Loss has 2013 year in the ScholarIQ index.

What is the open-access status of Reamputation after Minor Foot Amputation in Diabetic Patients: Risk Factors Leading to Limb Loss?

ScholarIQoa status

Reamputation after Minor Foot Amputation in Diabetic Patients: Risk Factors Leading to Limb Loss has green oa status in the ScholarIQ index.

What is the DOI of Reamputation after Minor Foot Amputation in Diabetic Patients: Risk Factors Leading to Limb Loss?

ScholarIQdoi

The DOI for Reamputation after Minor Foot Amputation in Diabetic Patients: Risk Factors Leading to Limb Loss is on the source record.

What is the PMID of Reamputation after Minor Foot Amputation in Diabetic Patients: Risk Factors Leading to Limb Loss?

ScholarIQpmid

The PMID for Reamputation after Minor Foot Amputation in Diabetic Patients: Risk Factors Leading to Limb Loss is on the source record.

What is the OpenAlex record for Reamputation after Minor Foot Amputation in Diabetic Patients: Risk Factors Leading to Limb Loss?

ScholarIQopenalex

The OpenAlex for Reamputation after Minor Foot Amputation in Diabetic Patients: Risk Factors Leading to Limb Loss is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial